LOS ANGELES -- The COVID-19 vaccines made by Pfizer and Moderna both require two doses to be administered, several weeks apart, for them to be fully effective. But there has been some scientific ...
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines. Trump health officials ...
Moderna has early in-human data showing its next-generation COVID-19 vaccine, mNEXSPIKE, has the potential to offer strong immune protection against the latest rapidly spreading SARS-CoV-2 virus.
Despite quarterly revenue totals that were nearly cut in half compared to the same period last year, Moderna still expects to ...
CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s ...
The Cambridge company has aggressively reduced costs through measures including staff cuts and lower spending on research and ...
Hosted on MSN
Moderna opens UK vaccine manufacturing facility
Moderna has opened the Moderna Innovation and Technology Centre (MITC), its new vaccine manufacturing and research and development (R&D) facility in Oxfordshire, UK. The facility, located at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback